About Celcuity (NASDAQ:CELC)
Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer. It is also developing CELx tests to diagnose 14 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, bladder, and hematological cancers. The company was founded in 2012 and is headquartered in Minneapolis, Minnesota.
Industry, Sector and Symbol
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CELC
CUSIPN/A
Phone763-392-0767
Debt
Debt-to-Equity RatioN/A
Current Ratio42.95%
Quick Ratio42.95%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$3.11 per share
Price / Book5.60
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees22
Outstanding Shares10,110,000
Celcuity (NASDAQ:CELC) Frequently Asked Questions
What is Celcuity's stock symbol?
Celcuity trades on the NASDAQ under the ticker symbol "CELC."
How were Celcuity's earnings last quarter?
Celcuity (NASDAQ:CELC) announced its quarterly earnings data on Thursday, March, 15th. The company reported ($0.17) EPS for the quarter. View Celcuity's Earnings History.
Who are some of Celcuity's key competitors?
Some companies that are related to Celcuity include GenMark Diagnostics (GNMK), BioTime (BTX), Adverum Biotechnologies (ADVM), Pacific Biosciences (PACB), Catalyst Biosciences (CBIO), Oxford Immunotec Global (OXFD), Merus (MRUS), NicOx (NICXF), Kadmon (KDMN), Tandem Diabetes Care (TNDM), Durect (DRRX), Seres Therapeutics (MCRB), Pulse Biosciences (PLSE), NantKwest (NK), Majesco Entertainment (COOL), 22nd Century Group (XXII), BioSpecifics Technologies (BSTC) and AVEO Pharmaceuticals (AVEO).
Who are Celcuity's key executives?
Celcuity's management team includes the folowing people:
- Mr. Brian F. Sullivan, Co-Founder, Chairman & CEO (Age 56)
- Dr. Lance G. Laing Ph.D., Co-Founder, Chief Science Officer, VP, Sec. & Director (Age 56)
- Ms. Vicky Hahne, CFO & Principal Accounting Officer (Age 52)
- Ms. Laura Beggrow RN, Chief Commercial Officer (Age 55)
- Mr. Larry Fitzgerald, VP of Strategic Partnerships & Managed Markets (Age 47)
When did Celcuity IPO?
(CELC) raised $18 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.
When did the company's lock-up period expire?
Celcuity's lock-up period expired on Monday, March 19th. Celcuity had issued 2,400,000 shares in its IPO on September 20th. The total size of the offering was $22,800,000 based on an initial share price of $9.50. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.
Has Celcuity been receiving favorable news coverage?
News articles about CELC stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Celcuity earned a coverage optimism score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 45.98 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Celcuity?
Shares of CELC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Celcuity's stock price today?
One share of CELC stock can currently be purchased for approximately $17.41.
How big of a company is Celcuity?
Celcuity has a market capitalization of $171.30 million. Celcuity employs 22 workers across the globe.
How can I contact Celcuity?
Celcuity's mailing address is 16305 36TH AVENUE N SUITE 450, MINNEAPOLIS MN, 55446. The company can be reached via phone at 763-392-0767.
MarketBeat Community Rating for Celcuity (CELC)
MarketBeat's community ratings are surveys of what our community members think about Celcuity and other stocks. Vote "Outperform" if you believe CELC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Celcuity (NASDAQ:CELC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Celcuity in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Celcuity (NASDAQ:CELC) Consensus Price Target History
Celcuity (NASDAQ:CELC) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/16/2017 | Craig Hallum | Initiated Coverage | Buy | | N/A |  |
(Data available from 4/21/2016 forward)
Celcuity (NASDAQ:CELC) Earnings History and Estimates Chart
Celcuity (NASDAQ CELC) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/15/2018 | Q4 2017 | | ($0.17) | | | View | N/A | |
| 11/13/2017 | Q3 2017 | | ($0.22) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Celcuity (NASDAQ:CELC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Celcuity (NASDAQ CELC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 43.50%
Institutional Ownership Percentage: 13.76%
Celcuity (NASDAQ CELC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/28/2017 | Richard Nigon | Director | Buy | 7,500 | $17.48 | $131,100.00 | | |
| 11/21/2017 | Richard Nigon | Director | Buy | 8,500 | $17.31 | $147,135.00 | | |
(Data available from 1/1/2013 forward)
Celcuity (NASDAQ CELC) News Headlines
| Source: |
|
Celcuity (NASDAQ:CELC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Celcuity (NASDAQ:CELC) Income Statement, Balance Sheet and Cash Flow Statement
Celcuity (NASDAQ CELC) Stock Chart for Saturday, April, 21, 2018
Loading chart…
